KARIUS RECEIVES US $165 MILLION FOR ITS INNOVATIVE LIQUID BIOPSY TECHNOLOGY TO IDENTIFY DISEASES

Highlights:

• Although the funds may have been raised under the looming threat of the novel coronavirus, the company’s technology is already being used in more than 100 hospitals.

• The technology helps test for infection-causing pathogens in immune-compromised pediatric patients using blood drawn.

• It is also effective in tests for potential causes of complex fungal infectio....